Amicogen Inc Total Liabilities

Latest as of March 2026: ₩80.33 Billion KRW ≈ $54.44 Million USD

Amicogen Inc total liabilities. Based on the latest financial reports, Amicogen Inc (092040) has total liabilities worth ₩80.33 Billion KRW (≈ $54.44 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 092040 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Amicogen Inc (2014–2025)

Total liabilities of Amicogen Inc from 2014 to 2025. This chart illustrates how Amicogen Inc's total liabilities have evolved over time, based on quarterly financial data. Explore 092040 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Amicogen Inc Competitors by Total Liabilities

The table below lists competitors of Amicogen Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Touchstone Exploration Inc TO:TXP	Canada	CA$164.80 Million
Advani Hotels & Resorts (India) Limited NSE:ADVANIHOTR	India	Rs287.04 Million
Shinil Electronics Co KO:002700	Korea	₩43.94 Billion
Theralase Technologies Inc. V:TLT	Canada	CA$1.28 Million
Grazziotin S.A SA:CGRA3	Brazil	R$372.38 Million
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- F:BLH	Germany	€1.05 Billion
Nila Spaces Limited NSE:NILASPACES	India	Rs-1.71 Billion
Lay Hong Bhd KLSE:9385	Malaysia	RM489.87 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Amicogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Amicogen Inc.

Liquidity & Leverage Metrics

Amicogen Inc Total Liabilities Ratios Explained

Amicogen Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amicogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amicogen Inc (2014–2025)

The table below shows the annual total liabilities of Amicogen Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩136.00 Billion ≈ $92.17 Million	-20.80%
2024-12-31	₩171.73 Billion ≈ $116.38 Million	-30.79%
2023-12-31	₩248.12 Billion ≈ $168.15 Million	-16.70%
2022-12-31	₩297.86 Billion ≈ $201.85 Million	+32.34%
2021-12-31	₩225.06 Billion ≈ $152.52 Million	+72.56%
2020-12-31	₩130.43 Billion ≈ $88.39 Million	+9.28%
2019-12-31	₩119.35 Billion ≈ $80.88 Million	+14.84%
2018-12-31	₩103.93 Billion ≈ $70.43 Million	+39.83%
2017-12-31	₩74.32 Billion ≈ $50.37 Million	+14.71%
2016-12-31	₩64.79 Billion ≈ $43.91 Million	-16.65%
2015-12-31	₩77.74 Billion ≈ $52.68 Million	+1688.10%
2014-12-31	₩4.35 Billion ≈ $2.95 Million	--

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.78 Million

₩64.61 Billion KRW

Market Cap Rank

#22213 Global

#1406 in Korea

Share Price

₩917.00

Change (1 day)

+0.11%

52-Week Range

₩822.00 - ₩3125.00

All Time High

₩22094.22